Helius Medical Technologies Revenue | HSDT

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Helius Medical Technologies

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.02 M	520 K	644 K	787 K	522 K	661 K	1.5 M	478 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.02 M	478 K	1.39 M

Quarterly Revenue Helius Medical Technologies

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.62 M	697 K	43 K	49 K	-	51 K	182 K	135 K	-	143 K	256 K	111 K	-	196 K	119 K	190 K	-	109 K	71 K	84 K	-	131 K	133 K	207 K	-	150 K	518 K	677 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.62 M	43 K	358 K

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical devices industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Pulmonx Corporation LUNG	90.5 M	$ 1.88	2.73 %	$ 76.5 M	USA
Medtronic PLC MDT	36.4 B	$ 87.97	1.88 %	$ 113 B	USA
MiMedx Group MDXG	419 M	$ 4.55	0.54 %	$ 672 M	USA
Myomo MYO	40.9 M	$ 1.67	2.45 %	$ 69.9 M	USA
Nano-X Imaging Ltd. NNOX	13 M	$ 0.64	1.15 %	$ 41.5 M	Israel
InspireMD NSPR	8.98 M	$ 0.58	1.64 %	$ 37.3 M	Israel
Orthofix Medical OFIX	822 M	$ 9.5	4.51 %	$ 376 M	Curacao
Outset Medical OM	119 M	$ 4.1	3.54 %	$ 62.4 K	USA
PAVmed PAVM	71 K	$ 2.66	4.36 %	$ 1.78 M	USA
Penumbra PEN	1.4 B	$ 317.11	0.07 %	$ 12.3 B	USA
Insulet Corporation PODD	2.71 B	$ 135.62	2.98 %	$ 9.54 B	USA
Profound Medical Corp. PROF	16.1 M	$ 6.03	3.25 %	$ 182 M	Canada
Quanterix Corporation QTRX	139 M	$ 3.81	4.67 %	$ 162 M	USA
AVITA Medical RCEL	71.6 M	$ 13.25	4.17 %	$ 369 M	Australia
Sintx Technologies SINT	1.02 M	$ 2.18	1.05 %	$ 6.05 M	USA
Smith & Nephew plc SNN	4.56 B	$ 26.92	1.87 %	$ 23.3 B	Britain
Sensus Healthcare SRTS	27.5 M	$ 2.92	0.34 %	$ 47.7 M	USA
Stryker Corporation SYK	7.17 B	$ 285.22	3.54 %	$ 109 B	USA
Tactile Systems Technology TCMD	330 M	$ 22.47	1.67 %	$ 514 M	USA
TELA Bio TELA	80.3 M	$ 1.14	0.88 %	$ 53.5 M	USA
TransMedics Group TMDX	605 M	$ 82.99	4.0 %	$ 2.82 B	USA
Tandem Diabetes Care TNDM	290 M	$ 16.52	0.12 %	$ 1.12 B	USA
Viemed Healthcare VMD	270 M	$ 9.24	1.2 %	$ 359 M	USA
Varex Imaging Corporation VREX	845 M	$ 18.45	0.14 %	$ 764 M	USA
Vivos Therapeutics VVOS	17.4 M	$ 0.15	1.52 %	$ 1.54 M	USA
Beyond Air XAIR	7.68 M	$ 2.84	0.71 %	$ 23.6 B	USA
Xtant Medical Holdings XTNT	134 M	$ 0.33	0.09 %	$ 46 M	USA
Zimmer Biomet Holdings ZBH	8.23 B	$ 91.57	3.72 %	$ 18.1 B	USA
Nemaura Medical NMRD	77 K	-	-17.8 %	$ 2.74 M	Britain
Neovasc NVCN	2.55 M	-	-	$ 111 M	Canada
Sientra SIEN	25.1 M	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	177 M	-	-	$ 1.07 B	USA
Surgalign Holdings SRGA	82 M	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	730 M	-	-	$ 12.3 B	USA
Titan Medical TMDI	20.1 M	-	-26.32 %	$ 19.6 M	Canada
Natus Medical Incorporated NTUS	473 M	-	1.94 %	$ 1.05 B	USA
Cardiovascular Systems CSII	236 M	-	0.15 %	$ 844 M	USA
Inari Medical NARI	494 M	-	-	$ 4.23 B	USA
Invacare Corporation IVC	181 M	-	-	$ 24.7 M	USA
NuVasive NUVA	1.2 B	-	-	$ 2.07 B	USA
Axonics Modulation Technologies AXNX	366 M	-	-	$ 3.31 B	USA
ThermoGenesis Holdings THMO	9.44 M	-	-25.84 %	$ 171 K	USA
Talis Biomedical Corporation TLIS	2.13 M	-	3.55 %	$ 7.96 M	USA
Viveve Medical VIVE	6.43 M	-	-15.35 %	$ 1.71 M	USA
ViewRay VRAY	102 M	-	1.54 %	$ 468 M	USA
SmileDirectClub SDC	471 M	-	-53.45 %	$ 9.71 M	USA
Acutus Medical AFIB	20.2 M	-	-26.83 %	$ 2.62 M	USA
BIOLASE BIOL	49.2 M	-	-13.19 %	$ 166 K	USA
Vapotherm VAPO	68.7 M	-	6.72 %	$ 34 M	USA
SeaSpine Holdings Corporation SPNE	191 M	-	0.28 %	$ 270 M	USA